Cargando…

A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice

Zika virus (ZIKV) is a re-emerging mosquito-borne flavivirus that affects humans and can cause severe neurological complications, including Guillain-Barré syndrome and microcephaly. Since 2007 there have been three large outbreaks; the last and larger spread in the Americas in 2015. Actually, ZIKV i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez, Patricia, Q. Marín, María, Lázaro-Frías, Adrián, Jiménez de Oya, Nereida, Blázquez, Ana-Belén, Escribano-Romero, Estela, S. Sorzano, Carlos Óscar, Ortego, Javier, Saiz, Juan-Carlos, Esteban, Mariano, Martín-Acebes, Miguel A., García-Arriaza, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255889/ https://www.ncbi.nlm.nih.gov/pubmed/30478418 http://dx.doi.org/10.1038/s41598-018-35724-6

Ejemplares similares

Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara
por: Jiménez de Oya, Nereida, et al.
Publicado: (2022)

Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus
por: Saiz, Juan-Carlos, et al.
Publicado: (2018)

Zika virus infection confers protection against West Nile virus challenge in mice
por: Vázquez-Calvo, Ángela, et al.
Publicado: (2017)

Response: Commentary: Zika Virus: the Latest Newcomer
por: Saiz, Juan-Carlos, et al.
Publicado: (2016)

The combined vaccination protocol of DNA/MVA expressing Zika virus structural proteins as efficient inducer of T and B cell immune responses
por: Pérez, Patricia, et al.
Publicado: (2021)

Zika Virus: the Latest Newcomer
por: Saiz, Juan-Carlos, et al.
Publicado: (2016)

Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
por: García-Arriaza, Juan, et al.
Publicado: (2021)

Dengue Virus Strikes Back: Increased Future Risk of Severe Dengue Disease in Humans as a Result of Previous Exposure to Zika Virus
por: Martín-Acebes, Miguel A., et al.
Publicado: (2020)

Neurological manifestations of Zika virus infection
por: Blázquez, Ana-Belén, et al.
Publicado: (2016)

The Scientific Response to Zika Virus
por: Martín-Acebes, Miguel A., et al.
Publicado: (2019)

Current Progress of Avian Vaccines Against West Nile Virus
por: Jiménez de Oya, Nereida, et al.
Publicado: (2019)

Antiviral Properties of the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus, Zika Virus, and Dengue Virus
por: Vázquez-Calvo, Ángela, et al.
Publicado: (2017)

West Nile Virus Replication Requires Fatty Acid Synthesis but Is Independent on Phosphatidylinositol-4-Phosphate Lipids
por: Martín-Acebes, Miguel A., et al.
Publicado: (2011)

COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice
por: García-Arriaza, Juan, et al.
Publicado: (2021)

Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace?
por: Martín-Acebes, Miguel A., et al.
Publicado: (2018)

A Single Amino Acid Substitution in the Core Protein of West Nile Virus Increases Resistance to Acidotropic Compounds
por: Martín-Acebes, Miguel A., et al.
Publicado: (2013)

Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B
por: Pérez, Patricia, et al.
Publicado: (2020)

Novel Nonnucleoside Inhibitors of Zika Virus Polymerase Identified through the Screening of an Open Library of Antikinetoplastid Compounds
por: Sáez-Álvarez, Yanira, et al.
Publicado: (2021)

Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
por: López-Camacho, César, et al.
Publicado: (2019)

Widespread distribution of hepatitis E virus in Spanish pig herds
por: Jiménez de Oya, Nereida, et al.
Publicado: (2011)

Pathogenicity and virulence of West Nile virus revisited eight decades after its first isolation
por: Saiz, Juan-Carlos, et al.
Publicado: (2021)

Lipid Metabolism as a Source of Druggable Targets for Antiviral Discovery against Zika and Other Flaviviruses
por: Martín-Acebes, Miguel A., et al.
Publicado: (2019)

A Recombinant Subviral Particle-Based Vaccine Protects Magpie (Pica pica) Against West Nile Virus Infection
por: Jiménez de Oya, Nereida, et al.
Publicado: (2019)

Previous Usutu Virus Exposure Partially Protects Magpies (Pica pica) against West Nile Virus Disease But Does Not Prevent Horizontal Transmission
por: Escribano-Romero, Estela, et al.
Publicado: (2021)

Mechanisms of Infection in Zika Virus
por: Blázquez, Ana Belén
Publicado: (2023)

An MVA Vector Expressing HIV-1 Envelope under the Control of a Potent Vaccinia Virus Promoter as a Promising Strategy in HIV/AIDS Vaccine Design
por: Pérez, Patricia, et al.
Publicado: (2019)

Infection with Usutu Virus Induces an Autophagic Response in Mammalian Cells
por: Blázquez, Ana-Belén, et al.
Publicado: (2013)

Editorial: Zika Virus Research
por: Bueno-Marí, Rubén, et al.
Publicado: (2018)

Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens
por: Nájera, José Luis, et al.
Publicado: (2010)

High susceptibility of magpie (Pica pica) to experimental infection with lineage 1 and 2 West Nile virus
por: Jiménez de Oya, Nereida, et al.
Publicado: (2018)

Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways
por: García-Arriaza, Juan, et al.
Publicado: (2013)

Protection against West Nile Virus Infection in Mice after Inoculation with Type I Interferon-Inducing RNA Transcripts
por: Rodríguez-Pulido, Miguel, et al.
Publicado: (2012)

Protection of a Single Dose West Nile Virus Recombinant Subviral Particle Vaccine against Lineage 1 or 2 Strains and Analysis of the Cross-Reactivity with Usutu Virus
por: Merino-Ramos, Teresa, et al.
Publicado: (2014)

Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression
por: Q. Marín, María, et al.
Publicado: (2018)

Modified Vaccinia virus Ankara but not vaccinia virus induces chemokine expression in cells of the monocyte/macrophage lineage
por: Lehmann, Michael H, et al.
Publicado: (2015)

Pharmacological Elevation of Cellular Dihydrosphingomyelin Provides a Novel Antiviral Strategy against West Nile Virus Infection
por: Jiménez de Oya, Nereida, et al.
Publicado: (2023)

A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV Immunogen
por: Vijayan, Aneesh, et al.
Publicado: (2015)

A Candidate HIV/AIDS Vaccine (MVA-B) Lacking Vaccinia Virus Gene C6L Enhances Memory HIV-1-Specific T-Cell Responses
por: García-Arriaza, Juan, et al.
Publicado: (2011)

Involvement of the Cellular Phosphatase DUSP1 in Vaccinia Virus Infection
por: Cáceres, Ana, et al.
Publicado: (2013)

Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic?
por: Saiz, Juan-Carlos, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l6jjgc189hcvi5bf1daecopiin